GT Biopharma Inc (GTBP)
3.05
+0.08
(+2.69%)
USD |
NASDAQ |
Nov 04, 16:00
2.95
-0.10
(-3.28%)
After-Hours: 20:00
GT Biopharma Price to Book Value: 1.237 for Nov. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 1.237 |
| November 01, 2024 | 1.205 |
| October 31, 2024 | 1.193 |
| October 30, 2024 | 1.221 |
| October 29, 2024 | 1.351 |
| October 28, 2024 | 1.339 |
| October 25, 2024 | 1.266 |
| October 24, 2024 | 1.225 |
| October 23, 2024 | 1.196 |
| October 22, 2024 | 1.030 |
| October 21, 2024 | 0.9818 |
| October 18, 2024 | 0.9291 |
| October 17, 2024 | 0.8561 |
| October 16, 2024 | 0.8114 |
| October 15, 2024 | 0.8074 |
| October 14, 2024 | 0.8313 |
| October 11, 2024 | 0.8317 |
| October 10, 2024 | 0.8114 |
| October 09, 2024 | 0.8398 |
| October 08, 2024 | 0.8459 |
| October 07, 2024 | 0.8378 |
| October 04, 2024 | 0.8196 |
| October 03, 2024 | 0.8534 |
| October 02, 2024 | 0.8723 |
| October 01, 2024 | 0.9007 |
| Date | Value |
|---|---|
| September 30, 2024 | 0.9368 |
| September 27, 2024 | 0.8601 |
| September 26, 2024 | 0.848 |
| September 25, 2024 | 0.8216 |
| September 24, 2024 | 0.8114 |
| September 23, 2024 | 0.7993 |
| September 20, 2024 | 0.8317 |
| September 19, 2024 | 0.8439 |
| September 18, 2024 | 0.8845 |
| September 17, 2024 | 0.9129 |
| September 16, 2024 | 0.8561 |
| September 13, 2024 | 0.8845 |
| September 12, 2024 | 0.8845 |
| September 11, 2024 | 0.8601 |
| September 10, 2024 | 0.8388 |
| September 09, 2024 | 0.8815 |
| September 06, 2024 | 0.7912 |
| September 05, 2024 | 0.8358 |
| September 04, 2024 | 0.8682 |
| September 03, 2024 | 0.8601 |
| August 30, 2024 | 0.8723 |
| August 29, 2024 | 0.886 |
| August 28, 2024 | 0.8885 |
| August 27, 2024 | 0.908 |
| August 26, 2024 | 0.8764 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6459
Minimum
May 31 2023
22.26
Maximum
Jun 02 2021
3.818
Average
2.629
Median
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.082 |
| Theriva Biologics Inc | 0.0803 |
| Oragenics Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 71.35 |
| Price | 3.05 |
| Earnings Yield | -249.0% |
| Market Cap | 6.815M |